Sign in
4

Changes in Ownership

ORAMED PHARMACEUTICALS INC. Filed Acc 0001209191-24-001146

Chief Financial Officer acquired 136,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Silberman David Chief Financial Officer 2024-01-04 Grant or award +136,500 366,500 D
Loading xslF345X05/doc4.xml…